Unlike the study in ovarian cancer, we did not observe FABP4 significant de novo expression in human tumor hepatocytes, suggesting that FABP4 produced by the endothelial cells exerts pro-oncogenic effects on hepatocytes during liver carcinogenesis. The gene discussed is FABP4; the disease is ovarian carcinoma.